JP2019512475A5 - - Google Patents

Download PDF

Info

Publication number
JP2019512475A5
JP2019512475A5 JP2018546423A JP2018546423A JP2019512475A5 JP 2019512475 A5 JP2019512475 A5 JP 2019512475A5 JP 2018546423 A JP2018546423 A JP 2018546423A JP 2018546423 A JP2018546423 A JP 2018546423A JP 2019512475 A5 JP2019512475 A5 JP 2019512475A5
Authority
JP
Japan
Prior art keywords
compound
disease
integer
compound according
ammonium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018546423A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019512475A (ja
JP6959246B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/020477 external-priority patent/WO2017151938A1/en
Publication of JP2019512475A publication Critical patent/JP2019512475A/ja
Publication of JP2019512475A5 publication Critical patent/JP2019512475A5/ja
Application granted granted Critical
Publication of JP6959246B2 publication Critical patent/JP6959246B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018546423A 2016-03-04 2017-03-02 治療に有効な量のジカルボン酸化合物を使用した、病気の予防、治療及び治癒 Active JP6959246B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662303960P 2016-03-04 2016-03-04
US62/303,960 2016-03-04
PCT/US2017/020477 WO2017151938A1 (en) 2016-03-04 2017-03-02 Prevention, treatment and reversal of disease using therapeutically effective amounts of dicarboxylic acid compounds

Publications (3)

Publication Number Publication Date
JP2019512475A JP2019512475A (ja) 2019-05-16
JP2019512475A5 true JP2019512475A5 (https=) 2020-04-09
JP6959246B2 JP6959246B2 (ja) 2021-11-02

Family

ID=59743189

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018546423A Active JP6959246B2 (ja) 2016-03-04 2017-03-02 治療に有効な量のジカルボン酸化合物を使用した、病気の予防、治療及び治癒

Country Status (6)

Country Link
US (2) US10751310B2 (https=)
EP (1) EP3440045B1 (https=)
JP (1) JP6959246B2 (https=)
CN (1) CN109071405A (https=)
CA (1) CA3016180A1 (https=)
WO (1) WO2017151938A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109803648A (zh) 2016-10-05 2019-05-24 高等教育联邦系统-匹兹堡大学 可逆保护的硫醇化亲电脂肪酸作为前药
US10765652B2 (en) 2016-10-05 2020-09-08 University of Pittsburgh—of the Commonwealth System of Higher Education Reversible nitroxide derivatives of nitroalkenes that mediate nitrosating and alkylating reactions
CN109200043A (zh) * 2018-10-23 2019-01-15 华南农业大学 二羧酸(盐)在降低脂肪沉积和预防肥胖方面的应用
US12390435B2 (en) 2018-11-14 2025-08-19 University of Pittsburgh—of the Commonwealth System of Higher Education Electrophiles and electrophile pro-drugs as RAD51 inhibitors
CA3209453A1 (en) * 2021-01-25 2022-07-28 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives therof, and their use for the prevention or treatment of disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1153464A (en) 1965-08-25 1969-05-29 Lepetit Spa Amino-Fluoro-Aliphatic Dicarboxylic Acids and a process for their preparation
US3527789A (en) * 1967-10-06 1970-09-08 Shell Oil Co Production of poly(lower)alkyl alkenepolycarboxylates
US4166913A (en) 1977-07-08 1979-09-04 Atlantic Richfield Company Preparation of unsaturated diesters by the catalytic oxidative carbonylation of diolefins with an enol ether and an alcohol
EP0344113A3 (de) * 1988-05-27 1990-10-31 Ciba-Geigy Ag Substituierte alpha-Pyrone und Naphthochinone
US6528499B1 (en) * 2000-04-27 2003-03-04 Georgetown University Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
WO2009017802A1 (en) 2007-08-01 2009-02-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Nitro-fattyacid modulation of type ii diabetes
PT2100604E (pt) 2008-03-10 2012-07-24 Nestec Sa Ácidos dicarboxílicos de cadeia média e os seus derivados e doenças metabólicas
WO2010005521A1 (en) 2008-06-30 2010-01-14 Bltn, Llc Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkers
WO2010014889A2 (en) 2008-08-01 2010-02-04 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Nitro fatty acids as regiomers and related mimetics
EP3045167A1 (en) 2009-07-31 2016-07-20 University of Pittsburgh - Of the Commonwealth System of Higher Education Keto fatty acids as anti-inflammatory agents
DE102011118462B4 (de) 2011-11-14 2021-07-22 Maximilian Born Energetische Polymere als reaktive Strukturmaterialien zur Verwendung für Waffensysteme
WO2013116753A1 (en) 2012-02-03 2013-08-08 University Of Pittsburgh-Of The Commonwelth System Of Higher Education Fatty acids as anti-inflammatory agents
EP2828231B1 (en) 2012-03-21 2019-11-06 P2 Science, Inc. Method for the production of Guerbet Alcohols
US9688944B2 (en) 2012-04-24 2017-06-27 Stepan Company Synergistic surfactant blends
JPWO2015012367A1 (ja) 2013-07-26 2017-03-02 宇部興産株式会社 トリカルボン酸、トリカルボン酸エステル、およびそれらを含有する電解コンデンサ用電解液
TWI515296B (zh) * 2013-10-11 2016-01-01 中央研究院 反式-烏頭酸化合物於抑制第七型磷酸二酯酶的用途及於製備藥品與保健食品的用途
CN103705499B (zh) 2013-12-13 2015-11-18 南京医科大学 二羧酸及其酯类化合物的应用
US20150216825A1 (en) * 2014-02-06 2015-08-06 University Of Houston System Organic acids as growth inhibitors of pathological calcification and uses thereof

Similar Documents

Publication Publication Date Title
JP2019512475A5 (https=)
IL297844A (en) Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids
HRP20230039T1 (hr) Benzotiadiazepinski spojevi i njihova uporaba kao modulatora žučnih kiselina
JP2019504899A5 (https=)
JP2019504898A5 (https=)
JP2018518537A5 (https=)
JP2020535225A5 (https=)
JP2019532928A5 (https=)
JP2018035142A5 (https=)
JP2009507846A5 (https=)
JP2023504647A5 (https=)
JP2014531434A5 (https=)
JP2020517694A5 (https=)
JP2011513367A5 (https=)
JP2018507223A5 (https=)
HRP20201954T1 (hr) Metode liječenja kolestatskih i fibrotičnih bolesti
JP2017512833A5 (https=)
JP2023513658A5 (https=)
JP2014515013A5 (https=)
JP2016529306A5 (https=)
JP2008521829A5 (https=)
JP2022541514A5 (https=)
JP2025509697A5 (https=)
JP2020502047A5 (https=)
JP2021500403A5 (https=)